About this document
CRAMS in India by Kushanspares is a document available to read on EtoBox.
The document discusses the Indian pharmaceutical sector. It is classified into four main segments: CRAMS, formulations, APIs, and biosimilars. The sector grew at an average 14% CAGR from 2008-2013 but slowed to 10% from 2013-2018 due to pricing regulations and slowing US growth. The government aims to boost the sector through initiatives like Ayushman Bharat and increasing healthcare expenditures. Indian companies receive many US FDA approvals annually, demonstrating the sector
- Author
- Kushanspares
- Language
- EN